Labcorp acquires MLM Medical Labs to expand clinical-trial services

Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to support complex multinational clinical trials through a coordinated laboratory network. Financial terms were not disclosed.

The transaction gives Labcorp wholly owned central-laboratory operations across North America, Europe, Asia and Africa. According to Labcorp, that makes it the only central-laboratory provider with a wholly owned network spanning four continents. MLM also brings an established, accredited central laboratory in Africa, an important addition to the group’s regional coverage. The announcement emphasized scientific capabilities and geographic reach, but did not quantify expected additional revenue, cost savings or earnings accretion.

Sources:

• Labcorp — MLM Medical Labs acquisition announcement